Forefront Analytics, LLC Rvl Pharmaceuticals PLC Transaction History

Forefront Analytics, LLC

  • $209 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 10, 2021
SELL
$2.8 - $3.78 $84,330 - $113,846
-30,118 Closed
0 $0
Q1 2021

May 13, 2021
BUY
$3.26 - $4.84 $39,208 - $58,210
12,027 Added 66.48%
30,118 $99,000
Q4 2020

Feb 12, 2021
SELL
$4.12 - $6.29 $10,563 - $16,127
-2,564 Reduced 12.41%
18,091 $72,000
Q3 2020

Nov 12, 2020
BUY
$4.82 - $8.77 $99,557 - $181,144
20,655 New
20,655 $111,000

Others Institutions Holding RVLP

# of Institutions
1
Shares Held
92.5K
Call Options Held
0
Put Options Held
0
View Full List

About RVL Pharmaceuticals plc

RVLP Quotes by TradingView
  • Ticker RVLP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 99,150,000
  • Description
  • RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an...
More about RVLP
Track This Portfolio

Track Forefront Analytics, LLC Portfolio

Follow Forefront Analytics, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Forefront Analytics, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Forefront Analytics, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email